Skip to main content
. 2017 Aug 9;11:2333–2346. doi: 10.2147/DDDT.S140164

Table 5.

Cancer cell growth inhibitory activity of compound 8c and sunitinib toward sensitive (A-549) and resistant NCI-H69AR cancer cell lines

Compound IC50 (µM)
Fold resistance
Sensitive A-549 Resistant NCI-H69AR
8c 1.3±1.5 9.5±0.6 7.5
Sunitinib 3.1±0.9 5.8±0.4 1.9

Abbreviation: IC50, inhibitory concentration 50%.